Human CYP19A1 (Aromatase) - Recombinant Protein
Beta LifeScience
SKU/CAT #: BLT-08708P
SDS-PAGE analysis of Human CYP19A1 (Aromatase) - Recombinant Protein, CAT# BLT-08708P showing >90% purity under 15% SDS-PAGE (Reduced)
Human CYP19A1 (Aromatase) - Recombinant Protein
Beta LifeScience
SKU/CAT #: BLT-08708P
Regular price
$59500
$595.00
Sale price$54500
$545.00Save $50
/
Quantity Pricing
| Pack Size | Price (USD) |
|---|---|
| 500 µg | $1,375 |
| 1 mg | $2,245 |
For direct online orders, quantity pricing will be displayed in cart when you add 5x100ug or 10x100ug
Submit an inquiry or email inquiry@betalifesci.com for a customization request or bulk order quote.
Connect with us via the live chat in the bottom corner to receive immediate assistance.
Product Overview
| Product Name | Recombinant Human Aromatase (CYP19A1) Protein |
| Product Overview | This recombinant human Aromatase (CYP19A1) protein includes amino acids 1-503 of the target gene is expressed in E.coli.The protein is supplied in lyophilized form and formulated in PBS pH 7.4, 0.01% SKL, 5% Trehalose, 1% Mannitolprior to lyophilization. |
| Target Uniprot Id | P11511 |
| Recommended Name | Aromatase |
| Gene Name | CYP19A1 |
| Synonyms | CP19A |
| Species | Human |
| Predicted Molecular Mass | 60 kDa |
| Expression System | E.coli |
| Expression Range | 1-503 |
| Tag | C-6His |
| Purity | >90% |
| Formulation | Lyophilized |
| Buffer | PBS pH 7.4, 0.01% SKL, 5% Trehalose, 1% Mannitol |
| Storage Condition | 1. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. 2. Avoid repeated freeze-thaw cycles. 3. Store working aliquots at 4°C for up to one week. 4. In general, protein in liquid form is stable for up to 6 months at -20°C/-80°C. Protein in lyophilized powder form is stable for up to 12 months at -20°C/-80°C. |
| Reconstitution Instruction | Briefly centrifuged the vial prior to opening to bring the contents to the bottom. Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. It is recommended to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. The default final concentration of glycerol is 50%. |
| Applications | Positive Control; Immunogen; SDS-PAGE; WB |
| Research Area | Cancer |
| Target Function | A cytochrome P450 monooxygenase that catalyzes the conversion of C19 androgens, androst-4-ene-3,17-dione (androstenedione) and testosterone to the C18 estrogens, estrone and estradiol, respectively. Catalyzes three successive oxidations of C19 androgens: two conventional oxidations at C19 yielding 19-hydroxy and 19-oxo/19-aldehyde derivatives, followed by a third oxidative aromatization step that involves C1-beta hydrogen abstraction combined with cleavage of the C10-C19 bond to yield a phenolic A ring and formic acid. Alternatively, the third oxidative reaction yields a 19-norsteroid and formic acid. Converts dihydrotestosterone to delta1,10-dehydro 19-nordihydrotestosterone and may play a role in homeostasis of this potent androgen. Also displays 2-hydroxylase activity toward estrone. Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase). |
| Subcellular Location | Endoplasmic reticulum membrane; Multi-pass membrane protein. Microsome membrane; Multi-pass membrane protein. |
| Protein Family | Cytochrome P450 family |
| Associated Diseases | Aromatase excess syndrome (AEXS); Aromatase deficiency (AROD) |
| Tissue Specificity | Widely expressed, including in adult and fetal brain, placenta, skin fibroblasts, adipose tissue and gonads. |
